X4 Pharmaceuticals Statistics
NASDAQ: XFORHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
2.81+0.04 (+1.44%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
X4 Pharmaceuticals by the numbers
X4 Pharmaceuticals has a market capitalization of $278.6 million based on 99.15M shares outstanding. Its trailing P/E ratio is 140.5. The stock trades 25.4% below its 50-day average and 27.9% below its 200-day average.
Average daily trading volume is 843.96K shares, or about $2.4 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
XFOR valuation vs. peer median
| Metric | XFOR | Peer median | Difference |
|---|---|---|---|
| Market cap | $278.60M | $259.98M | +7% |
| Avg. volume | 843.96K | 906.75K | -7% |
Peer median across 8 companies: LXEO, IKT, SABS, PALI, FATE, SRZN, STRO, LCTX.
Valuation
- Market cap
- $278.60M
- P/E (TTM)
- 140.50
- EPS (TTM)
- $0.02
- Shares outstanding
- 99.15M
Price and trading
- Previous close
- 2.77
- Open
- 2.74
- Day range
- 2.71 – 2.86
- 52-week range
- 2.70 – 4.83
- Beta
- —
- Volume
- 434.33K
- Average volume
- 843.96K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 4, 2026
Additional statistics
- Market Cap
- 278.60M
- Pe
- 140.50
- Forward Pe
- -3.66
- Eps
- 0.02
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 4.83
- Week52 Low
- 2.70
- Avg Volume
- 843.96K
- Shares Outstanding
- 99.15M
- Ma50
- 3.76
- Ma200
- 3.89
- Earnings Date
- Nov 4, 2026
- Pct From52w High
- -41.82%
- Pct From52w Low
- 4.07%